This was very beneficial to my learning, and also offered opportunities for me to be more proactive and better equipped to anticipate the needs of counsel. This really helped me to expand my network. 

I prepared the first draft of most of the ancillary documents such as corporate approvals, reviewed and revised a lot of the disclosures, participated in the review of key transactional documents such as the Share Purchase Agreement and the exit implementation agreement (which sets out in detail the distribution of cash proceeds following the sale of Lekela).

I additionally managed the Document checklist to keep tabs on the timeline and status of where we were in respect of each document to the detail. Following this, I would provide updates to the team and occasionally to the client.

I also managed the CDD (Customer Due Diligence) and KYC process which required me to liaise directly between the client and their lawyers requesting information from them and reviewing it alongside our LSC team in Delhi. 

This was a particularly interesting part of the team as it required a lot of analysis at times like considering whether some of the flagged entities/individuals were 'material' PEPs (politically exposed people) and analysing the various structure charts to identify if a related entity/individual required CDD to be conducted. I was then responsible for drafting a lot of the compliance related documentation such as a Risk Memo which provided an analysis of our findings.

Being involved in work with one of the leading energy platforms of scale and continuing to be deliver positive impact is a rewarding and fulfilling part of the job. Climate change risk and mitigation is not only a major consideration on most boardroom agendas, but also a vital part of accelerating the global transition towards renewable energy and addressing the risks that can acutely and disproportionately affect much of Africa."

"As Pfizer is a US listed company, we acted as English counsel and advised on the English law aspects of the transaction. As a result, my role centred around reviewing and commenting on documents from an English law perspective along with researching various legal questions that arose.

My first task was to review and comment on the board minutes, resolutions and other related documents which sought to approve a bonus share issuance and capital reduction. The purpose of the issuance and reduction was to create distributable reserves in order to pay future dividends to shareholders. To assist with the review process, I reached out to colleagues who had worked on the creation of the joint venture to see if they had helpful precedents and I referred to our corporate templates for guidance as to the necessary provisions that should be included from an English law perspective. It was great to have the opportunity to think about the legal importance and implications of provisions as well as experience first-hand how valuable knowledge sharing is within the team.

As the deal progressed, questions arose as to the implications of certain aspects of the Takeover Code and how these may impact current deal strategy or drafting decisions. For instance, clarifying the circumstances in which a Rule 9 waiver may be invalidated once it had been granted by the Panel was important due to the percentage of shares Pfizer would have in the joint venture. The turnaround times for these research tasks were often quite quick due to the live nature of the issues. This experience really helped me develop efficient research skills as well as produce concise, but thorough research summaries so that these could be passed on to partners. It was really exciting to see my research being relied on to advise the client and contribute to certain strategic decisions.

Not only was assisting with one of the largest ever demergers in Europe memorable, but the skills I learnt were extremely valuable and I employed them often throughout the rest of my seat!"

"The short timeline for the restructuring also required agility and some late nights! I loved having the opportunity to participate in the design of the scheme, which as a third-party release scheme across multiple guarantors based on Lehman necessity, was highly innovative at the time and provided the legal blueprint for several subsequent landmark restructurings (which I also had the pleasure of working on!).

In the end, the scheme was implemented by way of an Irish scheme only but for most of the timeline the plan was to run parallel English and Irish schemes, so we prepared a full suite of English scheme documentation, most notably the explanatory statement.

A huge highlight of the deal was getting the chance to work directly with people across the organisational structure of the client, a huge spectrum of advisers (including financial advisers, lending institutions and local law firms in a wide range of jurisdictions and restructuring consultancies).

The experience allowed me to test and hone my project management and drafting skills, and most importantly gave me a chance to play an active role in thinking out and implementing the legal structure of a groundbreaking restructuring.

I have been able to build pivotal internal and external contacts in the aviation space which have subsequently led to my involvement in several further aviation restructurings, including the Virgin Atlantic restructuring plan and Malaysia Airlines scheme in 2021.

I never expected to learn so much about the Cape Town Convention, it was something I had never heard of before NAC but as a result of working on this transaction and with the support of the firm, I am excited to be attending the 2021 September Cape Town Conference in Cambridge."

I was working on this transaction while sitting within the London Private Equity practice, working alongside Christopher Sullivan, Shimin Lee, Lianne Mizrahi, Megan Hodges, Lewis Barton, Haeyoung Kim and Kingsley Duru. That said, throughout the transaction, we collaborated extensively with other key practice areas within the firm including Finance, Intellectual Property, Antitrust, Incentives, not to mention our counterparts in different jurisdictions including our offices in Paris and New York.

Throughout the life of the deal, I was involved in drafting sections of key acquisition documents. I took a leading role in drafting and progressing the ancillary transactional documentation.

Advancing the due diligence process was another key role which I undertook on this deal. As a cohesive team, we reviewed extensive documentation and applied the necessary redactions to safeguard any sensitive information.

Working alongside the client and management to meet their specific needs was an enriching and enlightening experience. To commemorate this achievement, we all shared a moment of camaraderie at the signing drinks once the final signatures were in place. I truly enjoyed working with the Private Equity team and the wider Clifford Chance network, together with the client, to conclude this transaction.